Interview with Swee-Yeok CHU, CEO & President, EDBI/Bio One Capital
As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm…
Address: 250 North Bridge Road,#28-00 Raffles City Tower, Singapore 179101,Singapore
Tel: +65 6832 6832
Web: http://www.edbi.com/
Bio One Capital is a leading strategic investment firm headquartered in Singapore with a worldwide presence investing to drive growth opportunities within the knowledge and innovation-intensive sectors of Biomedical Sciences, Clean Technologies, Internet & Digital Media, as well as other strategic industry clusters with commercial potential. As a value adding investor, they create sustainable and synergistic partnerships with their portfolio companies, leveraging on their broad network of resources and experience to facilitate the companies’ organic growth in Asia and the world, through their operations in Singapore
Investment firm
As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm…
Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson. There is a clear correlation between an inclusive culture and innovation Creating a…
Claus Zieler discusses the Asia Pacific region’s importance to Bayer’s global operations, the company’s commitment to increasing its portfolio of innovative medicines, and the potential for innovation coming from Asian…
As a strong advocate for APAC, Roche Diagnostics’ Managing Director for Asia Pacific, Lance Little, shares his insights on the nuances of the markets in the region, the value proposition…
GEA, a global leader in pharma manufacturing solutions, has recently implemented a successful reorganization to increase their country-level presence both globally and across the Asia-Pacific region with the objective to…
Callum Bir explains Microsoft’s vision and strategy for leveraging the transformative power of technology in healthcare, particularly in terms of its world-leading capabilities in Artificial Intelligence. While Microsoft is ubiquitous, our…
According to A.T. Kearney Health Practice Partner Keith Lostaglio, Southeast Asia presents a significant growth opportunity to the pharma industry, and companies which develop effective digital platforms first will gain…
Frederik Beelaerts van Blokland, Panalpina’s regional head of marketing and sales for Asia Pacific, explains how the company’s focus on the Asia Pacific region is a key growth driver and…
Pierre Fabre Medicament’s MD for Asia Pacific, Ng Tian Wee, on the growing importance of the region for PF, the significance of choosing Singapore as a regional hub, and the…
Coming from DHL’s Customer Solutions & Innovation division, Leonora Lim, Vice President Life Sciences & Healthcare Asia Pacific, gives an insight into the increasingly demanding logistics needs of pharmaceutical clients…
Singapore’s location at the heart of the APAC region, expertise in logistics and cold chain management, and smart investment in infrastructure has helped make the Lion City an indisputable global…
Ong Wee Min, Executive Director of Sales, highlights why Marina Bay Sands is the venue of choice for many international and regional healthcare conferences, the importance of being a true…
Christopher Snook discusses his dual role as Head of Group Country Management as well as Country President for Singapore, highlighting the importance of adhering to in-house as well as country-specific…
See our Cookie Privacy Policy Here
